Cargando…
Targeting EZH2 as a novel therapeutic strategy for sorafenib‐resistant thyroid carcinoma
Thyroid carcinoma is the most common endocrine malignancy. Surgery, post‐operative selective iodine‐131 and thyroid hormone suppression were the most common methods for the therapy of thyroid carcinoma. Although most patients with differentiated thyroid carcinoma (DTC) showed positive response for t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584518/ https://www.ncbi.nlm.nih.gov/pubmed/31087496 http://dx.doi.org/10.1111/jcmm.14365 |